United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide dental paste usp, 0.1% is indicated for adjunctive treatment and for the temporary relief of symptoms associated with oral inflammatory lesions and ulcerative lesions resulting from trauma. triamcinolone acetonide dental paste usp, 0.1% is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations; it is also contraindicated in the presence of fungal, viral, or bacterial infections of the mouth or throat. pediatric use the safety and efficacy of triamcinolone acetonide dental paste usp, 0.1% in children is unknown. pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced hpa axis suppression and cushing's syndrome than mature patients because of a larger skin surface area to body weight ratio. administration of corticosteroid-containing dental pastes to children should be limited to the least amount compatible with an effective therapeutic regimen. chronic corticosteroid therapy may interfere

United States - English - NLM (National Library of Medicine)

encube ethicals private limited - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide ointment 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - triamcinolone acetonide (unii: f446c597ka) (triamcinolone - unii:1zk20vi6ty) - triamcinolone acetonide 10 mg in 1 ml - the intra-articular or soft tissue administration of kenalog-10 injection (triamcinolone acetonide injectable suspension, usp) is indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, synovitis, or osteoarthritis. the intralesional administration of kenalog-10 injection is indicated for alopecia areata; discoid lupus erythematosus; keloids; localized hypertrophic, infiltrated, inflammatory lesions of granuloma annulare, lichen planus, lichen simplex chronicus (neurodermatitis), and psoriatic plaques; necrobiosis lipoidica diabeticorum. kenalog-10 injection may also be useful in cystic tumors of an aponeurosis or tendon (ganglia). kenalog-10 injection is contraindicated in patients who are hypersensitive to any components of this product (see warnings: general ). intramuscular corticosteroid preparations are contraind

United States - English - NLM (National Library of Medicine)

ascend laboratories, llc - triamcinolone (unii: 1zk20vi6ty) (triamcinolone - unii:1zk20vi6ty) - triamcinolone 0.25 mg - triamcinolone acetonide cream usp is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. triamcinolone acetonide cream usp is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - triamcinolone acetonide, quantity: 40 mg/ml - injection, suspension - excipient ingredients: benzyl alcohol; sodium chloride; polysorbate 80; carmellose sodium; water for injections; sodium hydroxide; hydrochloric acid - intramuscular: the intramuscular administration of kenacort-a 40 (sterile triamcinolone acetonide suspension usp) is indicated for systemic corticosteroid therapy in such conditions as allergic diseases, dermatoses, or generalised rheumatoid arthritis and other connective tissue disorders. intramuscular administration is particularly valuable in such conditions where oral corticosteroid therapy is not feasible. intra-articular: kenacort-a 40 injection is indicated for intra-articular or intrasynovial administration and for injections into tendon sheaths as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: synovitis of osteoarthritis; rheumatoid arthritis; acute and subacute bursitis; acute gouty arthritis; epicondylitis; acute non-specific tenosynovitis; post-traumatic osteoarthritis.

United States - English - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.  triamcinolone acetonide cream is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

United States - English - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.  triamcinolone acetonide cream is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide dental paste usp, 0.1% is indicated for adjunctive treatment and for the temporary relief of symptoms associated with oral inflammatory lesions and ulcerative lesions resulting from trauma. triamcinolone acetonide dental paste usp, 0.1% is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations; it is also contraindicated in the presence of fungal, viral, or bacterial infections of the mouth or throat.

United States - English - NLM (National Library of Medicine)

liberty pharmaceuticals, inc. - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.  triamcinolone acetonide cream is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

United States - English - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide cream usp contains triamcinolone acetonide [pregna-1,4-diene-3,20-dione, 9-fluoro-11,21- dihydroxy-16,17-[(1-methylethylidene)bis- (oxy)]-, (11β,16α)-], with the empirical formula c24 h31 fo6 and molecular weight 434.50. cas 76-25-5. triamcinolone acetonide cream usp 0.025% contains: 0.25 mg of triamcinolone acetonide usp per gram in a water washable cream base consisting of  mineral oil (and) lanolin alcohol, isopropyl palmitate nf, propylene glycol stearate, propylene glycol usp, cetyl alcohol nf, sorbitan monostearate nf, polysorbate 60 nf, sorbic acid nf, polyoxyl (40) stearate nf, propylparaben nf, methylparaben nf and purified water usp. triamcinolone acetonide cream usp 0.1% contains: 1 mg of triamcinolone acetonide usp per gram in a water washable cream base consisting of  mineral oil (and) lanolin alcohol, isopropyl palmitate nf, propylene glycol stearate, propylene glycol usp, cetyl alcohol nf, sorbitan monostearate nf, polysorbate 60 nf, sorbic acid nf, polyo